5/3
05:54 pm
bpmc
Rating for BPMC
Report
Rating for BPMC
5/3
05:54 pm
bpmc
Rating for BPMC
Report
Rating for BPMC
5/3
03:00 pm
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
5/3
03:00 pm
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
5/3
10:20 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
5/3
10:20 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
5/3
05:49 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
5/3
05:49 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
5/2
08:10 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $97.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $97.00 price target on the stock.
5/2
07:53 am
bpmc
Rating for BPMC
Medium
Report
Rating for BPMC
5/2
07:53 am
bpmc
Rating for BPMC
Medium
Report
Rating for BPMC
4/26
11:13 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $110.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $110.00 price target on the stock.
4/26
11:13 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $110.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $110.00 price target on the stock.
4/26
11:12 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
4/26
10:31 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
4/26
10:31 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
4/26
08:11 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $97.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $97.00 price target on the stock.
4/26
08:11 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $125.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $125.00 price target on the stock.
4/26
05:33 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
4/26
05:33 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
4/10
11:20 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
4/10
11:20 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
4/10
10:58 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
4/10
10:58 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
2/26
08:09 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $97.00 price target on the stock.
Medium
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $97.00 price target on the stock.